Section 1 - Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017) - Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017) | Zoe
Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)
1Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017).
Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)
made under subsection 196B(2) of the
Veterans' Entitlements Act 1986
Compilation No. 1
Compilation date: 25 May 2020
Includes amendments up to: Amendment Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 44 of 2020) (F2020L00505)
The day of commencement of this Amendment Statement of Principles concerning ulnar neuropathy at the elbow is 25 May 2020.
About this compilation
This compilation
This is a compilation of the Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017) that shows the text of the law as amended and in force on 25 May 2020.
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
RMA-Red
Statement of Principles
concerning
ULNAR NEUROPATHY AT THE ELBOW
(Reasonable Hypothesis)
(No. 65 of 2017)
The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.
Dated 3 November 2017
Contents
1 Name
2 Commencement
3 Authority
4 Application
5 Definitions
6 Kind of injury, disease or death to which this Statement of Principles relates
7 Basis for determining the factors
8 Factors that must exist
9 Relationship to service
10 Factors referring to an injury or disease covered by another Statement of Principles
Schedule 1 - Dictionary
1 Definitions
1 Name
This is the Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017).
1 Commencement
This instrument commences on 4 December 2017.
2 Authority
This instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.
3 Application
This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.
4 Definitions
The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.
5 Kind of injury, disease or death to which this Statement of Principles relates
(1) This Statement of Principles is about ulnar neuropathy at the elbow and death from ulnar neuropathy at the elbow.
Meaning of ulnar neuropathy at the elbow
(2) For the purposes of this Statement of Principles, ulnar neuropathy at the elbow means an acquired persistent disturbance of function of the ulnar nerve in the region of the elbow, in the presence of:
(a) altered sensation, pain or weakness in the distribution of the ulnar nerve; and
(b) electrodiagnostic evidence that confirms impaired ulnar nerve conduction across the elbow.
Note 1: Ulnar nerve dysfunction may be localised to the arcade of Struthers, the medial intermuscular septum of the arm, the retroepicondylar groove of the medial epicondyle, humeroulnar aponeurotic arcade (cubital tunnel), or the outlet from flexor carpi ulnaris muscle (deep flexor pronator aponeurosis).
Note 2: Ulnar neuropathy at the elbow may coexist with carpal tunnel syndrome.
Death from ulnar neuropathy at the elbow
(3) For the purposes of this Statement of Principles, ulnar neuropathy at the elbow, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's ulnar neuropathy at the elbow.
Note: terminal event is defined in the Schedule 1 – Dictionary.
6 Basis for determining the factors
The Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that ulnar neuropathy at the elbow and death from ulnar neuropathy at the elbow can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.
Note: relevant service is defined in the Schedule 1 – Dictionary.
7 Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting ulnar neuropathy at the elbow or death from ulnar neuropathy at the elbow with the circumstances of a person's relevant service:
(1) having a fracture of the bones of the affected elbow, including fracture of the medial epicondyle of the humerus, before the clinical onset of ulnar neuropathy at the elbow;
(2) having trauma to the affected elbow within the two years before the clinical onset of ulnar neuropathy at the elbow;
Note: trauma to the affected elbow is defined in the Schedule 1 - Dictionary.
(3) performing repetitive and forceful activities involving flexion and extension of the affected elbow:
(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and
(b) where the repetitive and forceful activities have not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;
Note: Examples of repetitive and forceful activities include lifting, moving or carrying a load greater than ten kilograms, using hand saws or using large, hand-held power machinery, climbing vertical ladders, ammunitioning, using a hand-held piece of equipment such as a jackhammer or shovel, and overhead throwing.
(4) holding a tool, device or instrument in position, with the wrist in an extended position and the affected elbow in a flexed position:
(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;
(5) using the affected elbow as a support in a posture that is required as part of the activity being performed:
(a) with the forearm pronated on a hard surface, or holding the arm with the elbow flexed by 30° or more; and
(b) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and
(c) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;
Note: Examples of using the elbow as a support include bicycling in the aero position, firing a hand-held weapon, or being required to adopt this posture due to undertaking activity in a cramped or confined space.
(6) having a surgical procedure under general anaesthesia, within the two months before the clinical onset of ulnar neuropathy at the elbow;
(7) having a surgical procedure to the affected elbow, including elbow arthroscopy, within the one year before the clinical onset of ulnar neuropathy at the elbow;
(8) being hospitalised, or confined to bed in a supine position, for at least two days within the 30 days before the clinical onset of ulnar neuropathy at the elbow;
(9) daily self-propulsion of a manual wheelchair:
(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;
(10) having paraplegia at the time of the clinical onset of ulnar neuropathy at the elbow;
(11) using elbow or forearm crutches:
(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical onset of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical onset of ulnar neuropathy at the elbow;
(12) having an inflammatory or degenerative joint disease from the specified list of inflammatory and degenerative joint diseases, involving the affected elbow, at the time of the clinical onset of ulnar neuropathy at the elbow;
Note: specified list of inflammatory and degenerative joint diseases is defined in the Schedule 1 - Dictionary.
(13) having amyloidosis at the time of the clinical onset of ulnar neuropathy at the elbow;
Note: amyloidosis is defined in the Schedule 1 - Dictionary.
(14) having haemodialysis or peritoneal dialysis for at least the one year before the clinical onset of ulnar neuropathy at the elbow;
(15) having a cerebrovascular accident with hemiplegia, excluding transient ischaemic attack or transient symptoms with infarction, before the clinical onset of ulnar neuropathy at the elbow;
(16) having an external burn to the affected arm requiring hospitalisation, within the five years before the clinical onset of ulnar neuropathy at the elbow;
(17) being pregnant within the three months before the clinical onset of ulnar neuropathy at the elbow;
(18) having an infection involving the affected ulnar nerve in the region of the elbow at the time of the clinical onset of ulnar neuropathy at the elbow;
Note: Examples of an infection involving the affected ulnar nerve include Mycobacterium leprae (leprosy) and tuberculosis.
(19) smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of ulnar neuropathy at the elbow, and:
(a) smoking commenced at least five years before the clinical onset of ulnar neuropathy at the elbow; and
(b) where smoking has ceased, the clinical onset of ulnar neuropathy at the elbow has occurred within five years of cessation;
Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(20) having a lesion as specified at the elbow that compresses or displaces the affected ulnar nerve at the time of the clinical onset of ulnar neuropathy at the elbow;
Note: lesion as specified is defined in the Schedule 1 - Dictionary.
(21) having diabetes mellitus at the time of the clinical onset of ulnar neuropathy at the elbow;
(22) having acromegaly before the clinical onset of ulnar neuropathy at the elbow;
Note: acromegaly is defined in the Schedule 1 - Dictionary.
(23) having a fracture of the bones of the affected elbow, including fracture of the medial epicondyle of the humerus, before the clinical worsening of ulnar neuropathy at the elbow;
(24) having trauma to the affected elbow within the two years before the clinical worsening of ulnar neuropathy at the elbow;
Note: trauma to the affected elbow is defined in the Schedule 1 - Dictionary.
(25) performing repetitive and forceful activities involving flexion and extension of the affected elbow:
(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and
(b) where the repetitive and forceful activities have not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;
Note: Examples of repetitive and forceful activities include lifting, moving or carrying a load greater than ten kilograms, using hand saws or using large, hand-held power machinery, climbing vertical ladders, ammunitioning, using a hand-held piece of equipment such as a jackhammer or shovel, and overhead throwing.
(26) holding a tool, device or instrument in position, with the wrist in an extended position and the affected elbow in a flexed position:
(a) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;
(27) using the affected elbow as a support in a posture that is required as part of the activity being performed:
(a) with the forearm pronated on a hard surface, or holding the arm with the elbow flexed by 30° or more; and
(b) for a cumulative period of at least 90 hours, within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and
(c) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;
Note: Examples of using the elbow as a support include bicycling in the aero position, firing a hand-held weapon, or being required to adopt this posture due to undertaking activity in a cramped or confined space.
(28) having a surgical procedure under general anaesthesia, within the two months before the clinical worsening of ulnar neuropathy at the elbow;
(29) having a surgical procedure to the affected elbow, including elbow arthroscopy, within the one year before the clinical worsening of ulnar neuropathy at the elbow;
(30) being hospitalised, or confined to bed in a supine position, for at least two days within the 30 days before the clinical worsening of ulnar neuropathy at the elbow;
(31) daily self-propulsion of a manual wheelchair:
(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;
(32) having paraplegia at the time of the clinical worsening of ulnar neuropathy at the elbow;
(33) using elbow or forearm crutches:
(a) for a cumulative period of at least 60 hours within a continuous period of six months before the clinical worsening of ulnar neuropathy at the elbow; and
(b) where this activity has not ceased more than 30 days before the clinical worsening of ulnar neuropathy at the elbow;
(34) having an inflammatory or degenerative joint disease from the specified list of inflammatory and degenerative joint diseases, involving the affected elbow, at the time of the clinical worsening of ulnar neuropathy at the elbow;
Note: specified list of inflammatory and degenerative joint diseases is defined in the Schedule 1 - Dictionary.
(35) having amyloidosis at the time of the clinical worsening of ulnar neuropathy at the elbow;
Note: amyloidosis is defined in the Schedule 1 - Dictionary.
(36) having haemodialysis or peritoneal dialysis for at least the one year before the clinical worsening of ulnar neuropathy at the elbow;
(37) having a cerebrovascular accident with hemiplegia, excluding transient ischaemic attack or transient symptoms with infarction, before the clinical worsening of ulnar neuropathy at the elbow;
(38) having an external burn to the affected arm requiring hospitalisation, within the five years before the clinical worsening of ulnar neuropathy at the elbow;
(39) being pregnant within the three months before the clinical worsening of ulnar neuropathy at the elbow;
(40) having an infection involving the affected ulnar nerve in the region of the elbow at the time of the clinical worsening of ulnar neuropathy at the elbow;
Note: Examples of an infection involving the affected ulnar nerve include Mycobacterium leprae (leprosy) and tuberculosis.
(41) smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of ulnar neuropathy at the elbow, and:
(a) smoking commenced at least five years before the clinical worsening of ulnar neuropathy at the elbow; and
(b) where smoking has ceased, the clinical worsening of ulnar neuropathy at the elbow has occurred within five years of cessation;
Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(42) having a lesion as specified at the elbow that compresses or displaces the affected ulnar nerve at the time of the clinical worsening of ulnar neuropathy at the elbow;
Note: lesion as specified is defined in the Schedule 1 - Dictionary.
(43) having diabetes mellitus at the time of the clinical worsening of ulnar neuropathy at the elbow;
(44) having acromegaly before the clinical worsening of ulnar neuropathy at the elbow;
Note: acromegaly is defined in the Schedule 1 - Dictionary.
(45) inability to obtain appropriate clinical management for ulnar neuropathy at the elbow.
8 Relationship to service
(1) The existence in a person of any factor referred to in section 8, must be related to the relevant service rendered by the person.
(2) The factors set out in subsections 8(23) to 8(45) apply only to material contribution to, or aggravation of, ulnar neuropathy at the elbow where the person's ulnar neuropathy at the elbow was suffered or contracted before or during (but did not arise out of) the person's relevant service.
9 Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1) if a factor referred to in section 8 applies in relation to a person; and
(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;
then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.
Schedule 1 - Dictionary
Note: See Section 5
1 Definitions
In this instrument:
acromegaly means a chronic disease of adults resulting from hypersecretion of growth hormone after closure of the epiphyses.
amyloidosis means the accumulation of insoluble fibrillar proteins in organs or tissues of the body such that vital function is compromised.
lesion as specified means:
(a) benign or malignant neoplasm;
(b) bony fragment or foreign body;
(c) calcification;
(d) cyst;
(e) ganglion;
(f) gouty tophus;
(g) haemorrhage or haematoma;
(h) lymphoedema;
(i) scar;
(j) tuberculoma; or
(k) another pathological lesion that compresses or displaces the ulnar nerve.
Note: This definition includes thickening, scarring or calcification of the ulnar collateral ligament.
MRCA means the Military Rehabilitation and Compensation Act 2004.
pack-years of cigarettes, or the equivalent thereof in other tobacco products means a calculation of consumption where one pack-year of cigarettes equals 20 tailor-made cigarettes per day for a period of one calendar year, or 7 300 cigarettes. One tailor-made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight. One pack-year of tailor-made cigarettes equates to 7.3 kilograms of smoking tobacco by weight. Tobacco products mean cigarettes, pipe tobacco or cigars, smoked alone or in any combination.
relevant service means:
(a) operational service under the VEA;
(b) peacekeeping service under the VEA;
(c) hazardous service under the VEA;
(d) British nuclear test defence service under the VEA;
(e) warlike service under the MRCA; or
(f) non-warlike service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
specified list of inflammatory and degenerative joint diseases means:
(a) amyloid arthropathy;
(b) gout;
(c) haemophilic arthropathy;
(d) neuropathic arthropathy;
(e) nodular fasciitis;
(f) osteoarthritis;
(g) other inflammatory arthritis requiring treatment with a disease modifying agent or a biological agent;
(h) rheumatoid arthritis;
(i) sarcoidosis;
(j) systemic lupus erythematosus; or
(k) systemic sclerosis.
terminal event means the proximate or ultimate cause of death and includes the following:
(a) pneumonia;
(b) respiratory failure;
(c) cardiac arrest;
(d) circulatory failure; or
(e) cessation of brain function.
trauma to the affected elbow means a discrete event involving the application of significant physical force to or through the affected elbow joint, that causes:
(a) damage to the joint; and
(b) the development, within 24 hours of the event occurring, of symptoms and signs of pain, tenderness and altered range of movement of the elbow joint. In the case of sustained unconsciousness or the masking of pain by analgesic medication, these symptoms and signs must appear on return to consciousness or the withdrawal of the analgesic medication; and
(c) the persistence of these symptoms and signs for a period of at least seven days following their onset, save for where medical intervention for the trauma to that joint has occurred and that medical intervention involves one of the following:
(i) immobilisation of the elbow joint by splinting or similar external agent;
(ii) injection of a corticosteroid or local anaesthetic into that joint; or
(iii) surgery to that joint.
Note: Examples of acute trauma include dislocation of the elbow joint, tearing or stretching of the ulnar collateral ligament, and medial epicondyle apophysitis.
ulnar neuropathy at the elbow—see subsection 6(2).
VEA means the Veterans' Entitlements Act 1986.
Note: Endnotes
Note: Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.
If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.
Note: Endnote 2—Abbreviation key
o = order(s)
ad = added or inserted
Ord = Ordinance
am = amended
orig = original
amdt = amendment
par = paragraph(s)/subparagraph(s)
c = clause(s)
/sub‑subparagraph(s)
C[x] = Compilation No. x
pres = present
Ch = Chapter(s)
prev = previous
def = definition(s)
(prev…) = previously
Dict = Dictionary
Pt = Part(s)
disallowed = disallowed by Parliament
r = regulation(s)/rule(s)
Div = Division(s)
exp = expires/expired or ceases/ceased to have
reloc = relocated
effect
renum = renumbered
F = Federal Register of Legislation
rep = repealed
gaz = gazette
rs = repealed and substituted
LA = Legislation Act 2003
s = section(s)/subsection(s)
LIA = Legislative Instruments Act 2003
Sch = Schedule(s)
(md) = misdescribed amendment can be given
Sdiv = Subdivision(s)
effect
SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment
SR = Statutory Rules
cannot be given effect
Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification
SubPt = Subpart(s)
No. = Number(s)
underlining = whole or part not
commenced or to be commenced
Note: Endnote 3—Legislation history
Name
Registration
Commencement
Application, saving and transitional provisions
Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 65 of 2017)
7 November 2017F2017L01451
4 December 2017
Amendment Statement of Principles concerning ulnar neuropathy at the elbow (Reasonable Hypothesis) (No. 44 of 2020)
28 April 2020F2020L00505
25 May 2020
Note: Endnote 4—Amendment history
Provision affected
How affected
Schedule 1 – Dictionary – trauma to the affected elbow………